As Pharma Spending Continues to Plod Along, Multi-Platform Providers Seek Opportunities | GenomeWeb

San Francisco — Many of the firms in the BCW Index expect the challenging pharma spending environment that tempered sales of certain capital equipment in 2005 to continue into 2006. But they also believe that opportunities still exist to grow revenue, depending on the technologies being offered.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.